Samsara Inc vs Novo Nordisk A/S — how do they compare? Samsara Inc trades at $40.08 (market cap $23.49B), while Novo Nordisk A/S trades at $45.96 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 8.8× Samsara Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Samsara Inc pays none. Which is the better fit depends on your goals.
| IOT | NVO | |
|---|---|---|
Market Cap | $23.49B | $207.85B |
Sector | Technology | Health |
52-Week High | $45.22 | $63.98 |
52-Week Low | $24.25 | $35.29 |
Enterprise Value | $22.76B | $222.55B |
Dividend Yield | — | 3.81% |
Trailing returns across standard periods
Latest headlines on both assets
Samsara provides a connected operations cloud that uses IoT data to help businesses improve efficiency and safety. Its platform offers real-time visibility for fleet management, equipment monitoring, and industrial sites.
Read more on IOT →With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →